Author Title [ Type(Asc)] Year
Filters: First Letter Of Title is O  [Clear All Filters]
Journal Article
Lund, T.C., Cathey, S.S., Miller, W.P., Eapen, M., Andreansky, M., Dvorak, C.C., Davis, J.H., Dalal, J.D., Devine, S.M., Eames, G.M., et al. (2014). Outcomes after Hematopoietic Stem Cell Transplant for Children with I-Cell Disease.Biol Blood Marrow Transplant.
Auger-Quittet, S., Duny, Y., Daures, J.-P., and Quittet, P. (2014). Outcomes after (90) Yttrium-ibritumomab tiuxetan-BEAM in diffuse large B-cell lymphoma: a meta-analysis.Cancer Med.
Shah, K., and Sumer, H. (2019). Outcome of safety and efficacy of allogeneic mesenchymal stromal cell derived from umbilical cord for the treatment of osteoarthritis in a randomized blinded placebo-controlled trial.Ann Transl Med7, S154.
Skalska-Sadowska, J., Wachowiak, J., Skalska-Sadowska, J., Wachowiak, J., Zając-Spychała, O., Niewiadomska-Wojnałowicz, I., Januszkiewicz-Lewandowska, D., Balwierz, W., Pawińska-Wąsikowska, K., Goździk, J., et al. (2014). Outcome of refractory and relapsed acute myeloid leukemia in children treated during 2005-2011 - experience of the Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG).Contemp Oncol (Pozn)18, 48-53.
Kato, M., Manabe, A., Saito, A.M., Koh, K., Inukai, T., Ogawa, C., Goto, H., Tsuchida, M., and Ohara, A. (2014). Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG).Int J Hematol.
Van Den Neste, E., Schmitz, N., Mounier, N., Gill, D., Linch, D., Trneny, M., Milpied, N., Radford, J., Ketterer, N., Shpilberg, O., et al. (2015). Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study.Bone Marrow Transplant.
Chandrakasan, S., Marsh, R.A., Uzel, G., Holland, S.M., Shah, K.N., and Bleesing, J. (2016). Outcome of patients with NEMO deficiency following allogeneic hematopoietic cell transplant.J Allergy Clin Immunol.
Koenecke, C., Heim, D., van Biezen, A., Heuser, M., Aljurf, M., Kyrcz-Krzemien, S., Volin, L., de Souza, C.A., Gedde-Dahl, T., Sengeloev, H., et al. (2016). Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party.Bone Marrow Transplant.
Middeke, J.M., Fang, M., Cornelissen, J.J., Mohr, B., Appelbaum, F.R., Stadler, M., Sanz, J., Baurmann, H., Bug, G., Schäfer-Eckart, K., et al. (2014). Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.Blood.
Ferrara, F., and Picardi, A. (2020). Is outcome of older people with AML improving with new therapeutic approaches and stem cell transplantation?.Expert Rev Hematol.
Varma, A., Sui, D., Milton, D.R., Tang, G., Saini, N., Hasan, O., Mukherjee, A., Joseph, J.Joy, Bashir, Q., Rondon, G., et al. (2019). Outcome of Multiple Myeloma With Chromosome 1q Gain and 1p Deletion After Autologous Hematopoietic Stem Cell Transplantation: propensity-score matched analysis: Outcome of 1q+/1p- MM pts after auto-HCT.Biol Blood Marrow Transplant.
Beauverd, Y., Roosnek, E., Tirefort, Y., Dantin, C., Ansari, M., Tsopra, O., Masouridi-Levrat, S., and Chalandon, Y. (2016). Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index.Bone Marrow Transplant.
Chaudhry, Q.Un Nisa, Iftikhar, R., Satti, T.Mehmood, Mahmood, S.Kamran, Ghafoor, T., Shamshad, G.Umair, Shahbaz, N., Khan, M.Ali, Khattak, T.Azam, Rehman, J., et al. (2019). Outcome of Fludarabine Based Conditioning in High Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single Center Study from Pakistan.Biol Blood Marrow Transplant.
Bassir, S.Hossein, Kholy, K.El, Chen, C.-Y., Lee, K.Ha, and Intini, G. (2018). Outcome of early dental implant placement versus other dental implant placement protocols: A systematic review and meta-analysis.J Periodontol.
Al-Ayed, T., Rahman, N.Ur, Alturki, A., and Aljofan, F. (2018). Outcome of continuous renal replacement therapy in critically ill children: a retrospective cohort study.Ann Saudi Med38, 260-268.
Poire, X., Labopin, M., Cornelissen, J.J., Volin, L., Espiga, C.Richard, J Veelken, H., Milpied, N., Cahn, J.-Y., Yacoub-Agha, I., van Imhoff, G.W., et al. (2015). Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the Acute Leukemia Working Party (ALWP) of the European group of Blood and Marrow Transplantation (EBMT).Am J Hematol.
Locatelli, F., Masetti, R., Rondelli, R., Zecca, M., Fagioli, F., Rovelli, A., Messina, C., Lanino, E., Bertaina, A., Favre, C., et al. (2014). Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study.Bone Marrow Transplant.
Reismüller, B., Peters, C., Dworzak, M.N., Pötschger, U., Urban, C., Meister, B., Schmitt, K., Dieckmann, K., Gadner, H., Attarbaschi, A., et al. (2013). Outcome of Children and Adolescents With a Second or Third Relapse of Acute Lymphoblastic Leukemia (ALL): A Population-based Analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.J Pediatr Hematol Oncol.
Ruan, Y.-S., Wu, X.-D., Feng, X.-Q., He, Y.-L., Zhang, Y.-M., Pei, F.-Y., and Li, C.-F. (2015). [Outcome of childhood high-risk acute lymphoblastic leukemia treated with the ALL-BFM 95 protocol].Zhongguo Dang Dai Er Ke Za Zhi17, 327-331.
Lum, S.Han, Selvarajah, S., A, A.Deya-Marti, McNaughton, P., Sobh, A., Waugh, S., Burton-Fanning, S., Newton, L., Gandy, J., Z, Z.Nademi, et al. (2020). Outcome of autoimmune cytopenia after hematopoietic cell transplantation in primary immunodeficiency.J Allergy Clin Immunol.
Franssen, L.E., Raymakers, R.A.P., Buijs, A., Schmitz, M.F., van Dorp, S., Mutis, T., Lokhorst, H.M., and van de Donk, N.W.C.J. (2016). Outcome of allogeneic transplantation in newly diagnosed and relapsed/refractory multiple myeloma: long-term follow-up in a single institution.Eur J Haematol.
Pohlen, M., Groth, C., Sauer, T., Görlich, D., Mesters, R., Schliemann, C., Lenz, G., Müller-Tidow, C., Büchner, T., Berdel, W.E., et al. (2016). Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾60 years).Bone Marrow Transplant.
Ringdén, O., Boumendil, A., Labopin, M., Canaani, J., Beelen, D., Ehninger, G., Niederwieser, D., Finke, J., Stelljes, M., Gerbitz, A., et al. (2019). OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OVER 69 YEARS OF AGE WITH ACUTE MYELOID LEUKEMIA: ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT.Biol Blood Marrow Transplant.
Candoni, A., Rambaldi, A., Fanin, R., Velardi, A., Arcese, W., Ciceri, F., Lazzarotto, D., Lussana, F., Olivieri, J., Grillo, G., et al. (2019). Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Societ.Biol Blood Marrow Transplant.
Kurosawa, S., Shimomura, Y., Tachibana, T., Ishiyama, K., Ota, S., Kobayashi, T., Uchida, N., Fukushima, K., Ashida, T., Matsuoka, K.-I., et al. (2020). Outcome of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic/myeloproliferative neoplasms-unclassifiable: a retrospective nationwide study of the Japan Society for Hematopoietic Cell Transplantation: Allo-HSCT for patient.Biol Blood Marrow Transplant.